Preparation and characterisation of tetrandrine nanosuspensions and in vitro estimate antitumour activity on A549 lung cancer cell line

References

• Azad, M., et al., 2015. Enhanced physical stabilization of fenofibrate nanosuspensions via wet co-milling with a superdisintegrant and an adsorbing polymer. European journal of pharmaceutics and biopharmaceutics, 94, 372–385.
   PubMed Web of Science ®Google Scholar
• Bhakay, A., et al., 2014. Enhanced recovery and dissolution of griseofulvin nanoparticles from surfactant-free nanocomposite microparticles incorporating wet-milled swellable dispersants. Drug development and industrial pharmacy, 40 (11), 1509–1522.
   PubMed Web of Science ®Google Scholar
• Chen, J., et al., 2018. Development of dual-drug-loaded stealth nanocarriers for targeted and synergistic anti-lung cancer efficacy. Drug delivery, 25 (1), 1932–1942.
   PubMed Web of Science ®Google Scholar
• Chen, Z., et al., 2018. Tetrandrine suppresses lung cancer growth and induces apoptosis, potentially via the VEGF/HIF-1α/ICAM-1 signaling pathway. Oncology letters, 15 (5), 7433–7437.
   PubMed Web of Science ®Google Scholar
• Cheng, X., et al., 2019. TPGS-grafted and acid-responsive soy protein nanogels for efficient intracellular drug release, accumulation, penetration in 3D tumor spheroids of drug-resistant cancer cells. Materials science and engineering: c, 102, 863–875.
   PubMed Web of Science ®Google Scholar
• Das, R.K., et al., 2010. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine, 6 (1), 153–160.
   PubMed Web of Science ®Google Scholar
• Dibaei, M., et al., 2019. The effect of surface treatment on the brain delivery of curcumin nanosuspension: in vitro and in vivo studies. International journal of nanomedicine, 14, 5477–5490. Dovepress,
   PubMed Web of Science ®Google Scholar
• Feng, R.M., et al., 2019. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer communications, 39 (1), 22–34.
   PubMed Web of Science ®Google Scholar
• Feng, T., et al., 2008. Process induced disorder in crystalline materials: differentiating defective crystals from the amorphous form of griseofulvin. Journal of pharmaceutical sciences, 97 (8), 3207–3221.
   PubMed Web of Science ®Google Scholar
• Fu, T., et al., 2020. Study on the stabilization mechanisms of wet-milled cepharanthine nanosuspensions using systematical characterization. Drug development and industrial pharmacy, 46 (2), 200–208.
   PubMed Web of Science ®Google Scholar
• Gratton, S., et al., 2008. The effect of particle design on cellular internalization pathways. Proceedings of the national academy of sciences, 105 (33), 11613–11618.
   PubMed Web of Science ®Google Scholar
• Guo, J.J., et al., 2013. Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension. International journal of pharmaceutics, 441 (1-2), 227–233.
   PubMed Web of Science ®Google Scholar
• Guo, K.F., et al., 2016. A novel tetrandrine-loaded chitosan microsphere: characterization and in vivo evaluation. Drug design, development and therapy, 10, 1291–1298.
   PubMed Web of Science ®Google Scholar
• Han, M.H., et al., 2013. Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions. International journal of pharmaceutics, 455 (1-2), 85–92. ELSEVIER.
   PubMed Web of Science ®Google Scholar
• He, S., et al., 2019. Construction and evaluation of SAK-HV protein oral dosage form based on chitosan quaternary ammonium salt-PLGA microsphere. J drug target. 27 (10), 1–10.
   PubMed Web of Science ®Google Scholar
• Hu, T., et al., 2014. Preparation and characterization of tetrandrine-loaded PLGA nanocomposite particles by premix membrane emulsification coupled with spray-drying method. Yao xue xue bao = acta pharmaceutica sinica, 49 (11), 1607–1613.
   PubMedGoogle Scholar
• Jiang, Y.W., et al., 2019. Tetrandrine inhibits human brain glioblastoma multiforme GBM 8401 cancer cell migration and invasion in vitro. Environmental toxicology, 34 (4), 364–374.
   PubMed Web of Science ®Google Scholar
• Kou, B., et al., 2017. Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK/mTOR pathway in human bladder cancer cells. Oncology reports, 38 (5), 3137–3143.
   PubMed Web of Science ®Google Scholar
• Li, J.X., et al., 2019. The pharmaceutical multi-activity of metallofullerenol invigorates cancer therapy. Nanoscale, 11 (31), 14528–14539.
   PubMed Web of Science ®Google Scholar
• Li, S., et al., 2011. Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine. AAPS pharmscitech, 12 (3), 1011–1018.
   PubMed Web of Science ®Google Scholar
• Li, Y.J., et al., 2015. Globular protein-coated Paclitaxel nanosuspensions: interaction mechanism, direct cytosolic delivery, and significant improvement in pharmacokinetics. Mol pharm, 12 (5), 1450–1500.
   Web of Science ®Google Scholar
• Lien, J.C., et al., 2017. Tetrandrine induces programmed cell death in human oral cancer CAL 27 cells through the reactive oxygen species production and caspase-dependent pathways and associated with beclin-1-induced cell autophagy. Environmental toxicology, 32 (1), 329–343.
   PubMed Web of Science ®Google Scholar
• Liu, C.X., et al., 2018. Self-nanoemulsifying drug delivery system of tetrandrine for improved bioavailability: physicochemical characterization and pharmacokinetic study. Biomed research international, 2018, 1–10.
   Web of Science ®Google Scholar
• Liu, T., et al., 2016. Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy. Oncotarget, 7 (26), 40800–40815.
   PubMedGoogle Scholar
• Niu, N.N., et al., 2019. Design and synthesis of tetrandrine derivatives as potential anti-tumor agents against A549 cell lines. ChemistrySelect, 4 (1), 196–201.
   Web of Science ®Google Scholar
• Patel, C.M., et al., 2014. Preparation of fenofibrate nanoparticles by combined stirred media milling and ultrasonication method. Ultrasonics sonochemistry, 21 (3), 1100–1107.
   PubMed Web of Science ®Google Scholar
• Patel, P.J., et al., 2018. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes. Drug development and industrial pharmacy, 44 (12), 1942–1952.
   PubMed Web of Science ®Google Scholar
• Qiu, L., et al., 2019. Ursolic acid nanoparticles for oral delivery prepared by emulsion solvent evaporation method: characterization, in vitro evaluation of radical scavenging activity and bioavailability. Artificial cells, nanomedicine, and biotechnology., 49 (1), 610–621.
   Google Scholar
• Rajamani, S., et al., 2018. Augmented anticancer activity of naringenin-loaded TPGS polymeric nanosuspension for drug resistive MCF-7 human breast cancer cells. Drug development and industrial pharmacy, 44 (11), 1752–1761.
   PubMed Web of Science ®Google Scholar
• Saralkar, P., et al., 2017. Alginate nanoparticles containing curcumin and resveratrol: preparation, characterization, and in vitro evaluation against DU145 prostate cancer cell line. AAPS pharmscitech, 18 (7), 2814–2823.
   PubMed Web of Science ®Google Scholar
• Sheng, J.Y., et al., 2015. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption. ACS applied materials and interfaces, 7 (28), 15430–15441.
   PubMed Web of Science ®Google Scholar
• Tang, X.J., et al., 2014. Nanocarrier improves the bioavailability, stability and antitumor activity of camptothecin. International journal of pharmaceutics., 477 (1-2), 536–545.
   PubMed Web of Science ®Google Scholar
• Wali, A.F., et al., 2019. Natural products against cancer: review on phytochemicals from marine sources in preventing cancer. Saudi pharmaceutical journal, 27 (6), 767–777.
   PubMed Web of Science ®Google Scholar
• Wang, R., et al., 2019a. Paclitaxel-betulinic acid hybrid nanosuspensions for enhanced anti-breast cancer activity. Colloids and surfaces B: biointerfaces, 174, 270–279.
   PubMed Web of Science ®Google Scholar
• Wang, H., et al., 2019b. Development of daidzein nanosuspensions: preparation, characterization, in vitro evaluation, and pharmacokinetic analysis. International journal of pharmaceutics, 566, 67–76.
   PubMed Web of Science ®Google Scholar
• Wang, L.L., et al., 2017. Safety of nanosuspensions in drug delivery. Nanomedicine, 13 (2), 455–469.
   PubMed Web of Science ®Google Scholar
• Wang, Y.T., et al., 2019c. Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α- tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy. Journal of microencapsulation, 36 (6), 1–33.
   PubMed Web of Science ®Google Scholar
• Wei, Q.H., et al., 2016. Oral hesperidin-Amorphization and improved dissolution properties by controlled loading onto porous silica. International journal of pharmaceutics, 518, 253–263.
   Web of Science ®Google Scholar
• Xia, D.N., et al., 2010. Preparation of stable nitrendipine nanosuspensions using the precipitation–ultrasonication method for enhancement of dissolution and oral bioavailability. European journal of pharmaceutical sciences, 40 (4), 325–334.
   PubMed Web of Science ®Google Scholar
• Yallapu, M.M., et al., 2011. Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. Biomaterials, 32 (7), 1890–1905.
   PubMed Web of Science ®Google Scholar
• Yang, C.L., et al., 2018. Recent advances in the application of vitamin E TPGS for drug delivery. Theranostics, 8 (2), 464–485.
   PubMed Web of Science ®Google Scholar
• Yao, M.J., et al., 2017. Synergistic cytotoxic effects of arsenite and tetrandrine in human breast cancer cell line MCF-7. International journal of oncology, 51 (2), 587–598.
   PubMed Web of Science ®Google Scholar
• Ye, L.Y., et al., 2017. The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of A549/DDP cells and A549 cells. Cancer cell international, 17 (1), 40–50.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2017. Denatured protein-coated docetaxel nanoparticles: Alterable drug state and cytosolic delivery. International journal of pharmaceutics, 523 (1), 1–14.
   PubMed Web of Science ®Google Scholar
• Zhang, H.Y., et al., 2018. Tetrandrine suppresses cervical cancer growth by inducing apoptosis in vitro and in vivo. Drug design, development and therapy, 13, 119–127. [InsertedFromOnline
   PubMed Web of Science ®Google Scholar
• Zhang, J.M., et al., 2017. Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells. Scientific reports, 7 (1), 46057–46070.
   PubMed Web of Science ®Google Scholar
• Zhang, Z.X., et al., 2018. The plant alkaloid tetrandrine inhibits metastasis via autophagy-dependent Wnt/β-catenin and metastatic tumor antigen 1 signaling in human liver cancer cells. Journal of experimental & clinical cancer research, 37 (1), 7–18.
   PubMed Web of Science ®Google Scholar
• Zhao, Y.Q., et al., 2013. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers. International journal of nanomedicine, 8, 4169–4181.
   PubMed Web of Science ®Google Scholar
• Zheng, K., et al., 2019. Effect of particle size and polymer loading on dissolution behavior of amorphous griseofulvin powder. Journal of pharmaceutical sciences, 108 (1), 234–242.
   PubMed Web of Science ®Google Scholar
• Zuo, W.B., et al., 2018. Fabrication of multicomponent amorphous bufadienolides nanosuspension with wet milling improves dissolution and stability. Artificial cells, nanomedicine, and biotechnology, 46 (7), 1513–1522.
   PubMed Web of Science ®Google Scholar